Home › Funds › Boston Common Asset Management, LLC › EW

Boston Common Asset Management, LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Boston Common Asset Management, LLC reported holding 173,996 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 0.88% of its reported portfolio and ranking #28 among its reported holdings. Boston Common Asset Management, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)174.00K sh
Reported value held$15.02M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Boston Common Asset Management, LLC's EW position evolved

Boston Common Asset Management, LLC first disclosed a stake in EW in Q3 2023 at 235,420 shares (US$16.3M). The position peaked in Q1 2024 at 205,270 shares, worth US$19.6M. Across 13 filings, Boston Common Asset Management, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 173,996 shares valued at US$15.0M — an increase of 13,182 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 235.42K $16.31M New
Q4 2023 226.11K $17.24M Reduce
Q1 2024 205.27K $19.62M Reduce
Q2 2024 199.95K $18.47M Reduce
Q3 2024 207.92K $13.72M Add
Q4 2024 152.53K $11.29M Reduce
Q1 2025 135.31K $9.81M Reduce
Q2 2025 150.86K $11.80M Add
Q3 2025 135.68K $10.55M Reduce
Q4 2025 149.55K $12.75M Add
Q1 2026 156.30K $12.52M Add
Q2 2026 160.81K $14.55M Add
Q3 2026 174.00K $15.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Boston Common Asset Management, LLC held EW?

Boston Common Asset Management, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Common Asset Management, LLC's current position in EW?

As of Q3 2026, Boston Common Asset Management, LLC holds 174.00K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $15.02M, representing 0.88% of its reported portfolio and ranking #28.

Has Boston Common Asset Management, LLC been buying or selling EW?

In the latest 13F filing (Q3 2026), Boston Common Asset Management, LLC increased its position in EW. The position peaked in Q1 2024 at 205.27K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.